C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular DiseaseP.M. Burger, Pim A. de Jong, Aernoud T.L. Fiolet et al.|Journal of the American College of Cardiology|2023Cited by 134
Colchicine for secondary prevention of ischaemic stroke and atherosclerotic events: a meta-analysis of randomised trialsAernoud T.L. Fiolet, Peter J. Kelly, Nathan Mewton et al.|EClinicalMedicine|2024Cited by 56
Colchicine for secondary prevention of vascular events: a meta-analysis of trialsMarc-André d’Entremont, Sanjit S. Jolly, Nathan Mewton et al.|European Heart Journal|2025Cited by 43
Individual lifetime benefit from low-dose colchicine in patients with chronic coronary artery diseaseP.M. Burger, Jeroen Schaap, Aernoud T.L. Fiolet et al.|European Journal of Preventive Cardiology|2023Cited by 16